AbbVie Combo hepatitis C treatment gets FDA Approval

December 20, 2014 12:11 PM

7 0

AbbVie Combo hepatitis C treatment gets FDA Approval

The Food and Drug Administration (FDA) has approved a treatment for chronic hepatitis C. With this approval, a new option has been made available for patients of chronic hepatitis C to treat their liver-damaging virus. The combination treatment has been developed by AbbVie.

The FDA on Friday gave its nod for the sale of a packaged treatment called Viekira Pak, made by AbbVie Inc. of North Chicago, Illinois. The treatment comprises a combination pill, which contains the antiviral drugs ombitasvir, paritaprevir and ritonavir, along with a tablet of dasabuvir.

Read more

To category page

Loading...